Elzbieta M. van der Steen‐Banasik
Radiotherapiegroep(NL)Erasmus MC Cancer Institute(NL)
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Bladder and Urothelial Cancer Treatments, Estrogen and related hormone effects, Prostate Cancer Diagnosis and Treatment
Most-Cited Works
- → Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts(2016)833 cited
- → Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials(2015)412 cited
- → Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial(2009)271 cited
- → Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy(2018)269 cited
- → PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer(2020)241 cited
- → Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991(2016)